A conceptual approach to the masking effect of measures of disproportionality

Pharmacoepidemiology and Drug Safety

Volumn 23, Issue 2, 2014, Pages 208-217

  Maignen, Francois ^a   Hauben, Manfred ^b,c,d,e   Hung, Eric ^b   Holle, Lionel Van ^f   Dogne, Jean Michel ^g  

^a EUROPEAN MEDICINES AGENCY   (United Kingdom)

^b PFIZER INC   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e BRUNEL UNIVERSITY   (United Kingdom)

^f GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^g UNIVERSITY OF NAMUR   (Belgium)

Author keywords

Algorithm; Disproportionality analysis; Masking; Pharmacoepidemiology

Indexed keywords

ALGORITHM; ARTICLE; CONCEPTUAL FRAMEWORK; CONTINGENCY TABLE; DATA BASE; DRUG SURVEILLANCE PROGRAM; MASKING EFFECT (STATISTICS); MATHEMATICAL ANALYSIS; MATHEMATICAL PARAMETERS; PRIORITY JOURNAL; SIMULATION; STATISTICAL CONCEPTS;

ALGORITHM; DISPROPORTIONALITY ANALYSIS; MASKING; PHARMACOEPIDEMIOLOGY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALGORITHMS; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; MODELS, THEORETICAL; PHARMACOEPIDEMIOLOGY; PHARMACOVIGILANCE; PUBLIC HEALTH;

EID: 84892858902     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3530     Document Type: Article

References (20)

1. Hauben M., Aronson JK. Defining 'Signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions. Drug Saf 2009; 32(2): 99-110.
2. Gould AL. Practical pharmacovigilance analysis strategies. Pharmacoepidemiol Drug Saf 2003; 12(7): 559-574.
3. Bate A, Evans SJW. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf 2009; 18(6): 427-436.
4. Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001; 10(6): 483-486.
5. Evans SJ. Statistical methods of signal detection in Mann R and Andrews E. Pharmacovigilance (2nd edn), John Wiley and Sons, Ltd.: Chichester, England, 2007.
6. Wang HW, Hochberg AM, Pearson RK, Hauben M. An experimental investigation of masking in the US FDA adverse event reporting system database. Drug Saf 2010; 33(12): 1117-1133.
7. Zeinoun Z, Seifert H, Verstraeten T. Quantitative signal detection for vaccines: effects of stratification, background and masking on GlaxoSmithkline's spontaneous reports database. Hum Vaccin 2009; 5(9): 599-607.
8. Pariente A, Didailler M, Avillach P, et al. A potential competition bias in the detection of safety signals from spontaneous reporting databases. Pharmacoepidemiol Drug Saf 2010; 19(11): 1166-1171.
9. Almenoff J, Tonning JM, Gould AL, et al. Perspectives on the Use of Data Mining in Pharmacovigilance. Drug Saf 2005; 28(11): 981-1007.
10. Guideline on the use of statistical signal detection tools in the EudraVigilance data analysis system (Doc. Ref. EMEA/106464/2006 rev. 1). The guideline can be accessed at the following URL www.ema.europa.eu/pdfs/human/phvwp/10646406enfin.pdf [17 May 2011].
11. Alvarez Y, Hidalgo A, Maignen F, Slattery J. Validation of statistical signal detection procedures in EudraVigilance post-authorisation data. A retrospective evaluation of the potential for earlier signalling. Drug Saf 2010; 33(6): 475-487.
12. Breslow NE, Day NE. General considerations for the analysis of case-control studies in Statistical methods in cancer research, Volume 1 the analysis of case-control studies. International Agency for Research on Cancer. Lyon 1980. The textbook is available on line at the following URL http://w2.iarc.fr/en/publications/pdfs-online/stat/sp32/SP32_vol1-0.pdf [17 August 2012].
13. Miettinen OS. Components of the crude risk ratio. Am J Epidemiol 1972; 96: 168-172.
14. Juhlin K, X, Ye, K, Star, G.N., Norén Outlier removal to uncover patterns in adverse drug reaction surveillance - a simple unmasking strategy. Pharmacoepidemiol Drug Saf. 2013; 22: 1119-1129.
15. Maignen F, Hauben M, Hung E, Van Holle L., Dogne JM. Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases (submitted for publication).
16. Loughlin AM, Marchant CD, Adams W, et al. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine 2012; 30(50): 7253-7259.
17. Lalmohamed A, de Vries F, Bazelier MT, et al. Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ 2012; 345: e5085.
18. Stang PE, Ryan PB, Racoosin JA, et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med 2010; 153: 600-606.
19. Platt R, Carnahan RM, Brown JS, et al. The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction. Pharmacoepidemiol Drug Saf 2012; 21(Suppl S1): 1-8.
20. Report of CIOMS Working group VIII. Practical aspects of signal detection in pharmacovigilance. Geneva 2010.